Clinical Trial Update: The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia [Phase 1, Phase 2]

View source ↗

Summary

This document discusses a Phase 1/Phase 2 clinical trial evaluating a three-drug combination (atorvastatin, acetylcysteine, and danazol) for steroid-resistant o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Acetylcysteine (Acetylcysteine)
• Danazol (danazol)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Immune Thrombocytopenia | Phase 1, Phase 2 | Status: UNKNOWN